Loading viewer...
investor_presentation
Format: PDF investor_presentation
Schrödinger presents Q2 FY24 business update highlighting its science-based software and consulting solutions for pharmaceutical R&D. The company focuses on accelerating drug development timelines and reducing costs through innovative computational tools and the integration of recently acquired Immunetrics business.
investor_presentation
Ramelius Resources
investor_presentation
29 Pages
investor_presentation
Hyundai